Form 25 Clearside Biomedical,
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING
AND/OR REGISTRATION UNDER SECTION 12(b)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-37783
Clearside Biomedical, Inc.
The Nasdaq Stock Market LLC
(Exact name of Issuer as specified in its charter, and name of Exchange
where security is listed and/or registered)
900 North Point Parkway, Suite 200
Alpharetta, GA 30005
(678) 270-3631
(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)
Common Stock, par value $0.001 per share
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
| ☐ | 17 CFR 240.12d2-2(a)(1) |
| ☐ | 17 CFR 240.12d2-2(a)(2) |
| ☐ | 17 CFR 240.12d2-2(a)(3) |
| ☐ | 17 CFR 240.12d2-2(a)(4) |
| ☐ | Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. |
| ☒ | Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange. |
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, Clearside Biomedical, Inc. certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
| December 8, 2025 | By | /s/ Charles A. Deignan | Chief Financial Officer | |||||||
| Date | Name | Title |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds
- Following White House Small Business Summit, SBA and GSA Take Action to Prioritize American-Made Products in Federal Purchasing
- Cushing crude stocks sit less than 2 mmbbls above operational floor amid global supply crisis
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
